Gustavo Denegri
Gustavo Denegri (born March 1937)[2] is an Italian billionaire businessman, the chairman of DiaSorin, an Italian biotechnology company.[1]
Gustavo Denegri | |
|---|---|
| Born | March 1937 (age 83) |
| Nationality | Italian |
| Alma mater | University of Turin |
| Known for | Owner of 44% of DiaSorin |
| Net worth | US$2.8 billion (August 2018)[1] |
| Title | Chairman, DiaSorin |
| Children | 2 |
He has a bachelor's degree in chemistry from the University of Turin.[3]
Denegri owns 44% of DiaSorin via IP Investimenti e Partecipazioni, a holding company controlled by his family.[4] By 2020, Forbes estimated his net worth at $3.1 billion.[5]
He is married with two children, and lives in Turin, Italy.[1]
References
- "The World's Billionaires: Gustavo Denegri". Forbes. Retrieved 23 January 2017.
- "Gustavo DENEGRI - Personal Appointments (free information from Companies House)". Beta.companieshouse.gov.uk. 2010-03-19. Retrieved 2017-01-23.
- Gustavo Denegri. "Gustavo Denegri: Executive Profile & Biography". Bloomberg. Retrieved 2017-01-23.
- "From Vespas To Pharma: Gustavo Denegri Becomes Italy's Newest Biotech Billionaire". Forbes.com. Retrieved 2017-01-23.
- Rogers, Taylor Nicole. "A pharmaceutical company just announced a rapid-result coronavirus test — and its billionaire owner made $100 million". Business Insider. Retrieved 2020-03-12.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.